Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice. - Wikidata - wikimedia - TriplyDB

Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice.

Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice.

http://www.wikidata.org/entity/Q35066122

about

Vaccinations for Neuroinfectious Disease: A Global Health Priority Cryptococcus and Phagocytes: Complex Interactions that Influence Disease Outcome New insights on the development of fungal vaccines: from immunity to recent challenges Vaccine immunity against fungal infections Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis The CD4+ T-lymphocyte count is an important predictor for the prognosis of cryptococcosis.STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice.Fungal vaccines and immunotherapeutics.Depletion of neutrophils in a protective model of pulmonary cryptococcosis results in increased IL-17A production by γδ T cells.Is Development of a Vaccine against Cryptococcus neoformans Feasible?Isolated biliary cryptococcosis manifesting as obstructive jaundice in an immunocompetent adult Role of Sterylglucosidase 1 (Sgl1) on the pathogenicity of Cryptococcus neoformans: potential applications for vaccine development.Vaccine and immunotherapeutic approaches for the prevention of cryptococcosis: lessons learned from animal models.Induction of Protective Immunity to Cryptococcal Infection in Mice by a Heat-Killed, Chitosan-Deficient Strain of Cryptococcus neoformans.Antifungal Activity of Plasmacytoid Dendritic Cells against Cryptococcus neoformans In Vitro Requires Expression of Dectin-3 (CLEC4D) and Reactive Oxygen Species.The intracellular life of Cryptococcus neoformans.Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responses Induction of protective immunity against cryptococcosis.New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis.Universal fungal vaccines: could there be light at the end of the tunnel?Cryptococcus antigens and immune responses: implications for a vaccine.CD4+ T Cells Orchestrate Lethal Immune Pathology despite Fungal Clearance during Cryptococcus neoformans Meningoencephalitis.Induction of Broad-Spectrum Protective Immunity against Disparate Cryptococcus Serotypes.A Call to Arms: Quest for a Cryptococcal Vaccine.IFN-γ immune priming of macrophages in vivo induces prolonged STAT1 binding and protection against Cryptococcus neoformans

P2860

Q26252588-E50BF9E9-F707-4A8B-9831-1BBB0EE174F6 Q26767978-F00F4E16-F0B4-480B-AD4C-B6DF19F4E9DA Q26776056-EA996AF5-2448-4A7E-BEFB-45C153ED0FE5 Q27009819-FA6A963A-4785-493C-B4D2-C463A1AAE46B Q28818603-643D32EF-8994-462F-93A5-75CCC324DC6F Q33575765-2ABC3EC9-F30D-4DD8-B429-12ECEAB64E4A Q34289451-84F7A518-99FD-40B2-85FB-AB0C07E6BDFD Q34400249-C9804606-A61E-4582-B181-1B766173AEA6 Q34502561-6AB4D1AF-0D30-4041-A025-3BCB73B69915 Q35667534-8E5E599E-3C60-4907-99A7-6B48A3B04E58 Q35816551-4E0A3A73-DF7D-40FD-8EE9-E6580CE7679C Q35938253-DFF26FBE-73E9-4A3B-96DC-C43A94A08AA7 Q36192774-6541CEFA-7030-4AD9-B64C-B99A8DE9D014 Q37123421-A97C22EE-972C-483E-90D9-575B1750183D Q37199814-F58F8C25-C870-4EFA-BF32-D50A370554D5 Q37452401-EE7D2867-C33A-4EA2-9A5E-4B6AB4B516D6 Q37562226-496F3A1F-6B14-46B7-99D2-2FB1E1D63784 Q37965038-83F26349-657D-461F-AEEC-EA66C5BEA922 Q38024052-7D482E23-9A8B-4AD1-94AB-7B9A2051F157 Q38038044-D8B65CAD-85F0-43EB-ABB1-46DB77F3FE7E Q38155197-A6D8EAB9-3D5C-4B23-A5F6-1F1B26B3BA4F Q46784433-0F652662-6D24-46BB-B2B8-782B61C090E7 Q47118458-46BA5CB7-5088-4933-B54B-9C724768D124 Q50149203-1C8F36C8-D136-4FF2-9061-EF0D807372F3 Q57286224-4AF46CAC-08B2-44AD-BC18-77C1E1AE40FC

P2860

Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice.

http://www.wikidata.org/entity/Q35066122

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Protective immunity against ex ...... cosis in T cell-depleted mice.

@ast

Protective immunity against ex ...... cosis in T cell-depleted mice.

@en

type

label

Protective immunity against ex ...... cosis in T cell-depleted mice.

@ast

Protective immunity against ex ...... cosis in T cell-depleted mice.

@en

prefLabel

Protective immunity against ex ...... cosis in T cell-depleted mice.

@ast

Protective immunity against ex ...... cosis in T cell-depleted mice.

@en

P1433

Q35066122-2EED4FC5-AD9F-42D2-8026-63F7AA52F6A2

P1476

Q35066122-83C1D020-D4A7-4F47-97A4-EBC2E5608E0C

P2093

Q35066122-0839358C-6403-4856-BD11-CF9F8C1168EC

Q35066122-9599AE41-A337-4882-BF65-C12811E98A94

Q35066122-C780533F-E112-4861-8027-A10B6EED8F06

P2860

Q35066122-0373745A-0A25-4E08-9676-54000922BB0D

Q35066122-09CBBC91-65BC-4CDD-BC82-18538EFBA0FD

Q35066122-0C74F7DD-C84F-4051-9F31-6DFFF5FA49AC

Q35066122-107EEA3F-79FD-4C16-A3BE-FCFF8CE1BBE4

Q35066122-1B67180C-EB48-44CD-AD7B-A8177A336105

Q35066122-1C11FCFD-7701-4186-AAA4-DAEE21122D8D

Q35066122-2047611D-C432-46F7-8019-C500D623CAA4

Q35066122-3D86E97E-0BFD-461F-9734-2C1652A06D07

Q35066122-47D8D7D9-BFFB-415A-B582-B06181783B55

Q35066122-4F02311B-91C6-40E3-B3B3-0510DB127180

P304

Q35066122-BE10B0D1-24DD-4318-9718-CA9B508C0161

P31

Q35066122-06AF9F48-9667-4888-99B3-BE3A16B75E1A

P356

Q35066122-23B45E3D-D403-4994-BDB4-3946B42B4F5F

P433

Q35066122-987F1470-6906-4BD9-9359-6D4B517B6CF3

P478

Q35066122-8FCADA84-2D07-4CFC-92E0-68C0EFEF78B9

P577

Q35066122-5F2D772D-1EB9-491E-885B-6AAE25D6D6FA

P698

Q35066122-7853A48D-BB6A-4D4F-ABBA-643BB1B8E1F7

P921

Q35066122-F998D627-9CE2-4FB1-A563-5974C59C8568

P932

Q35066122-563CF42E-4A6F-42B9-8F11-F438441C5E89

P356

P1433

Clinical and Vaccine Immunology

P1476

Protective immunity against ex ...... cosis in T cell-depleted mice.

@en

P2093

Floyd L Wormley

http://www.w3.org/2001/XMLSchema#string

Karen L Wozniak

http://www.w3.org/2001/XMLSchema#string

Mattie L Young

http://www.w3.org/2001/XMLSchema#string

P2860

Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome

Central memory and effector memory T cell subsets: function, generation, and maintenance

Innate or adaptive immunity? The example of natural killer cells

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.

Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection.

Cellular and molecular regulation of vaccination with heat shock protein 60 from Histoplasma capsulatum.

Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study.

P304

717-723

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CVI.00036-11

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21450975

http://www.w3.org/2001/XMLSchema#string

P921

P932

3122518

http://www.w3.org/2001/XMLSchema#string